A Phase II Study of Adding the Multikinase Inhibitor Sorafenib (Nexavar) to Existing Endocrine Therapy in Patient with Advanced Breast Cancer

  • Massarweh, Suleiman (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date9/18/07 → 9/30/10